Cui, J., Zhang, Y., Su, D., Li, T., & Li, Y. (2018). Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenografts. Thorac Cancer.
Chicago ZitierstilCui, Jiadong, Yan Zhang, Di Su, Tao Li, und Yu Li. "Efficacy of Combined Icotinib and Pemetrexed in EGFR Mutant Lung Adenocarcinoma Cell Line Xenografts." Thorac Cancer 2018.
MLA ZitierstilCui, Jiadong, et al. "Efficacy of Combined Icotinib and Pemetrexed in EGFR Mutant Lung Adenocarcinoma Cell Line Xenografts." Thorac Cancer 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.